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Abstract
Engineered nanomaterials (ENMs) are increasingly incorporated into a variety of commer-
cial applications and consumer products; however, ENMs may possess cytotoxic properties
due to their small size. This study assessed the effects of two commonly used ENMs, zinc
oxide nanoparticles (ZnONPs) and silver nanoparticles (AgNPs), in the model eukaryote
Saccharomyces cerevisiae. A collection of4600 S. cerevisiae deletion mutant strains was
used to deduce the genes, whose absence makes S. cerevisiae more prone to the cytotoxic
effects of ZnONPs or AgNPs. We demonstrate that S. cerevisiae strains that lack genes
involved in transmembrane and membrane transport, cellular ion homeostasis, and cell wall
organization or biogenesis exhibited the highest sensitivity to ZnONPs. In contrast, strains
that lack genes involved in transcription and RNA processing, cellular respiration, and endo-
cytosis and vesicular transport exhibited the highest sensitivity to AgNPs. Secondary
assays confirmed that ZnONPs affected cell wall function and integrity, whereas AgNPs
exposure decreased transcription, reduced endocytosis, and led to a dysfunctional electron
transport system. This study supports the use of S. cerevisiae Gene Deletion Array as an
effective high-throughput technique to determine cellular targets of ENM toxicity.
Introduction
Engineered nanomaterials (ENMs) are increasingly integrated into everyday life. ENMs pos-
sess unique physical, chemical, and structural properties attributable to their small size (100
nm in at least one dimension) [1]. Zinc oxide nanoparticles (ZnONPs) and silver nanoparticles
(AgNPs) are among the most commonly used ENMs. ZnONPs are present in numerous con-
sumer products, especially in ultraviolet (UV) blocking cosmetics [2, 3]. ZnONPs effectively
absorb UV-A and UV-B light through a process called band-gap absorption, and are less
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photoactive than titanium dioxide nanoparticles (TiO2NPs), which are also used in sunscreens
[4]. The photocatalytic properties of ZnONPs have also been extensively studied in relation to
degradation of organic pollutants, including various dyes and acetaldehyde that are used
industrially and released as effluents [5–7]. ZnONPs also have biocidal/antimicrobial proper-
ties [8, 9] that are thought to be mediated by the release of zinc ions (Zn2+) and generation of
reactive oxygen species (ROS) [10]. These properties have been extensively studied in relation
to potential antiviral and anti-cancer treatments [11–15], as well as antifouling agents [16].
On the other hand, AgNPs are well known as effective growth inhibitors of a wide range of
Gram-positive and Gram-negative bacteria and some viruses, and as such they are incorpo-
rated into a wide range of consumer products [17]. The antimicrobial actions of AgNPs may
involve (i) release of silver ions (Ag+), which mainly bind to thiol-containing compounds
thereby disrupting important cellular functions, including DNA replication, (ii) attachment to
cell membranes, which disrupts the membrane potential, and (iii) generation of ROS [18]. The
ability of AgNPs to generate ROS is applicable not only in antimicrobial/antiviral applications,
but also in pollutant degradation [19–20], as well as cancer treatment [20–21].
Despite the potentially beneficial properties of ENMs, concerns about their safety have been
raised over the past decade. It has been estimated that sludge-treated soil would be the main
environmental compartment for deposition of ZnONPs and AgNPs, and could accumulate
1.6–23.1 and 0.5–4.1 μg/kg/y of NPs, respectively [22]. This suggests that organisms in the soil
would be at a greater risk to adverse effects of ENMs. The overall health of microorganism
populations is of particular concern given their key contributions to the ecosystem, including
nitrogen fixation and nutrient cycling. Several studies have shown a plethora of effects by
ZnONPs and AgNPs on various bacterial species, including oxidative stress and damage, as
well as uptake and damage to various cellular components (reviewed by [23]). However, very
few studies have addressed the toxicity of ZnONPs and AgNPs in eukaryotic microorganisms.
Kasemets et al. [24] examined the toxicity of ZnONPs in the budding yeast (Saccharomyces cer-
evisiae) and reported that growth was inhibited by 80% at 250 mg/L ZnO for both nano-scale
and bulk forms. Moreover, it was suggested that growth inhibition was due to the release of
Zn2+ ions and possible induction of oxidative stress. In contrast, a lower concentration of 50
mg/L AgNPs was necessary to inhibit yeast growth [25]. The latter study reported that cellular
proteins, amino acids, and RNA molecules, as well as the plasma membrane were possibly
affected by AgNPs. Notably, generation of hydroxyl radicals and induction of apoptosis were
suggested as toxicity mechanisms for AgNPs in another yeast species, Candida albicans [26].
The current study uses a Gene Deletion Array (GDA) as a platform for a high-throughput
functional genomic screening to enhance our understanding of ENM toxicity. The GDA is
comprised of4600 non-essential gene deletion strains of S. cerevisiae. We predict that strains
with deletion of genes in a parallel, redundant pathway to that targeted by ZnONPs and/or
AgNPs, will have increased sensitivity to these NPs, as was demonstrated for other compounds
[27–30]. Highly sensitive strains are then categorized according to the cellular activity and
function of the deleted genes, in order to deduce cellular pathways that are affected by these
NPs. Thus, we examined the chemical-genetic profiles of ZnONPs and AgNPs using the GDA
platform and validated the findings with follow-up assays.
Materials and methods
2.1. Chemicals
ZnONPs in powder form (catalog #544906; particle size 50–70 nm) were purchased from
Sigma-Aldrich (Oakville, ON, Canada). An aqueous dispersion of AgNPs (2 mg/mL; 31%
silver content; particle size 1–10 nm) was purchased from Sciventions Inc (Toronto, ON,
Nanoparticles toxicity
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Canada). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), sodium
azide, glucose, MES (2-morpholinoethanesulfonic acid), DMSO (dimethyl sulfoxide),
geneticin (G418), CCCP (carbonyl cyanide 3-chlorophenylhydrazone), and MUG (4-methy-
lumbelliferyl-D-galactopyranoside) were purchased from Sigma-Aldrich. DiSBAC2(3) [bis-
(1,3-diethylthiobarbituric acid)trimethine oxonol] was purchased from Life Technologies
(Carlsbad, CA, USA).
2.2. NPs preparation and characterization
ZnONPs were suspended in 95% ethanol at a concentration of 10 mg/mL and sonicated
(Vibra Cell VCX130, Sonics & Materials Inc., Newtown, CT, USA) for 5 min. This stock solu-
tion was then diluted to 1 mg/mL in YPD medium (1% yeast extract, 2% peptone, 2% dex-
trose). The aqueous solution of silver nanoparticles (AgNPs; 0.62 mg/mL total silver) was
diluted to 0.095 mg/mL in YPD medium.
The size of ZnONPs and AgNPs was assessed using dynamic light scattering (DLS) with a
Zetasizer NanoZS according to the manufacturer’s guidelines (Malvern Instruments Ltd. Mal-
vern, Worcestershire, UK). Each sample was measured at least 3 times, and the obtained values
were used to calculate the average. The size of nanoparticles was verified using transmission
electron microscopy (TEM). The TEM images of the nanoparticles were obtained using a FEI
Tecnai G2 Spirit TEM with a Lab6 emitter operating at 120 kV. Prior to analysis, nanoparticles
were prepared as follows. The ZnONPs powder was dispersed in ethanol (EtOH) to form a
ZnO/EtOH dispersion. The aqueous dispersion of silver nanoparticles was diluted in water.
Both ZnO/EtOH and Ag/H2O dispersions were sonicated for 10 min using a BRANSON 3510
Ultrasonic Cleaner (Marshall Scientific, Hampton, NH, USA). The TEM specimen was pre-
pared by placing a small drop of ZnO/EtOH or Ag/H2O dispersion onto a TEM copper grid
supported with carbon film, then dried at room temperature.
2.3. Yeast strains and growth conditions
Yeast cells (S. cerevisiae) strains S288C (MATα SUC2 gal2 mal2 mel flo1 flo8-1 hap1 ho bio1
bio6) or W303 (MATa/MATα {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15}) were
grown in YPD medium at 30 ˚C for 1–2 days. Deletion strains were arrayed on YPD medium
that was supplemented with 2% agar and 200 μg/mL kanamycin (G418).
2.4. Minimum inhibitory concentrations and sensitivity analyses
The minimum inhibitory concentrations (MIC100) for ZnONPs and AgNPs were assessed
according to the Reference Method for Broth Dilution Antifungal Susceptibility Testing of
Yeasts M-27-A2 [31] and drop-out assays [32]. An overnight culture of yeast (S288C) cells was
10-fold serially diluted to obtain 105 cells/mL. For microdilution assays, different concentra-
tions of ZnONPs (0.25–5 mg/mL) and AgNPs (0.005–0.1 mg/mL) were assayed to determine
the corresponding MIC values. Microtitre plates were incubated at 30 ˚C for 24 h, and inhibi-
tory activity was evaluated by reading the absorbance at 600 nm using a FLUOstar Optima
multi-mode microplate reader (BMG Labtech, Ortenberg, Hessen, Germany). The MIC100
(the lowest concentration that resulted in complete inhibition of visible growth in liquid
medium) at 48 h was calculated using the equation:
100   ½ðAbsexp   AbsblankÞ  ðAbscarrier   Abscarrier blankÞ  100 ð1Þ
Where Absexp is the absorbance of the treated (with ZnONPs or AgNPs) sample (medium and
yeast cells), Absblank is the absorbance of the medium (no cells and no nanoparticles), Abscarrier
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is the absorbance of the carrier (solvent used to prepare the nanoparticles) with yeast cells used
as a growth control, and Abscarrier blank is the absorbance of the medium and the carrier with-
out cells. The MIC values were used as a guide to determine the sub-inhibitory concentrations
of ZnONPs and AgNPs for GDA analyses. Colonies from two plates were randomly chosen
from the GDA mutant set and replicated onto YPD-agar plates containing a range of ZnONPs
(0.1–1.5 mg/mL) or AgNPs (0.003–0.12 mg/mL) concentrations. Plates were incubated at
30 ˚C for 1–2 days and colony sizes were measured to identify the concentration of ZnONPs
or AgNPs that reduced the colony size by at least 30% in 5–10% of the strains compared to
control. The appropriate sub-inhibitory concentrations determined in this way were used for
full scale GDA analyses.
2.5. High-throughput phenotypic screening
Approximately 4600 haploid gene deletion strains of S. cerevisiae were exposed to a sub-inhibi-
tory concentration of ZnONPs and AgNPs nanoparticles (1 mg/mL and 0.095 mg/mL,
respectively). Plates were incubated for 1–2 d at 30 ˚C and digital images of these plates were
acquired. The area of the colonies was determined from the images as explained elsewhere
[33]. The size of each colony was compared to the average size for all colonies on both experi-
mental and control plates [29, 34]. Each experiment was carried out in triplicate. Colonies
with size reduction of at least 50% in at least two replicate experiments were classified as highly
sensitive strains. Functional clustering of the highly sensitive mutants was performed accord-
ing to eukaryotic orthologous groups (KOG), GeneMania, and Gene Ontology (GO) term
finder through the Saccharomyces Genome Database (SGD) [35–37].
Mutant strains identified as highly susceptible to ZnONPs and/or AgNPs by the large-scale
screening above were verified using drop-out assays [32, 38] on YPD-agar plates with and
without the sub-inhibitory concentration of 1 mg/mL ZnONPs or 0.095 mg/ml AgNPs. Plates
were incubated at 30 ˚C for 1–2 d and enumeration of colony forming units was performed to
estimate growth inhibition.
2.6. Cell membrane disruption analyses
2.6.1. Liposomes. Membrane disruption by ZnONPs was examined according to Cruz
et al. [39]. Briefly, liposomes were prepared as described by Cheetham et al. [40] with dioleoyl-
phosphatidylcholine to encapsulate carboxyfluorescein in large unilamellar vesicles (LUVs;
~100 nm in diameter). LUVs were suspended in iso-osmotic buffer (100 mM NaCl, 10 mM
HEPES, pH 7.4) and aliquoted into a 96-well microplate (black/clear Optilux flat bottom; BD
Bioscience, San Jose, CA, USA). ZnONPs were diluted in the iso-osmotic buffer and added to
the LUVs at a final concentration range of 0.03 to 0.2 mg/mL. The iso-osmotic buffer was used
as a negative control. Fluorescence threshold value was identified by the fluorescent signal of
the LUV suspension alone. Fluorescence intensity (485 nm ex./528 nm em.) was measured
using a Cytation 5 cell imaging multi-mode reader (BioTek, Winooski, VT, USA). Liposomes
were incubated for 1 h at room temperature in the dark prior to obtaining fluorescent emission
readings. The percent leakage (%L) was calculated by the equation:
%L ¼ bðF   F0Þ  ðF100   F0Þc  100 ð2Þ
Where F is fluorescence intensity after incubation of liposomes with ZnONPs or iso-osmotic
buffer (negative control), F0 is the fluorescence intensity of the liposomes in the buffer solu-
tion, F100 is fluorescence intensity corresponding to 100% leakage after the addition of triton
X-100 (10% v/v) for 10 min.
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2.6.2. Trypan blue stain. Membrane integrity was examined using the vital dye trypan
blue [41, 42]. Yeast cells were grown overnight in YPD medium to mid-log phase and adjusted
to approximately 104 cells/mL based on absorbance at 600 nm. Yeast cultures were subjected
to concentrations of ZnONPs ranging from 0.1 to 1.5 mg/mL. Control cells were treated with
equivalent volumes of 95% ethanol. Overnight cultures of treated cells were adjusted to a den-
sity of 107 cells/mL, and mixed (1:1) with a 0.4% trypan blue solution. The viable (unstained)
and non-viable (stained) cells were counted separately using a hemocytometer and a micro-
scope (CARL ZEISS #4649608, Oberkochen, Ostalbkreis, Germany). Observations were per-
formed in triplicate and averaged.
2.6.3. Depolarization analysis. The effect of ZnONPs on cell membrane depolarization
was examined using flow cytometry. Yeast cells were incubated overnight and cell density was
adjusted to 107 cells/mL. Yeast cultures were treated for 3 h with either 1.0 mg/mL ZnONPs,
10 mM citric acid (negative control), or 20 μM CCCP (positive control). Cells were then cen-
trifuged (9300 x g, 2 min) and washed twice with phosphate buffered saline (PBS). After stain-
ing with 5 μM DiSBAC2(3) for 30 min at 23 ˚C, the cells were subjected to flow cytometry
analysis (BD Accuri C6, BD Biosciences, East Rutherford, NJ, USA) using a red laser (488 nm
ex./585±40 nm em.). Samples were injected at a speed of 36 μL/min, and 10–10000 events
were measured per sample. Forward scatter (FSC) and side scatter (SSC) were simultaneously
measured. An increase in fluorescence intensity in the FL2-H range of 104–105 was expected
for cells with depolarized membranes [43].
2.7. Cell wall disruption analysis
Cell wall disruption was assessed according to Cruz et al. [39]. Yeast cells were grown in YPD
with sub-inhibitory concentrations of ZnONPs (0.5–1.5 mg/mL) overnight at 30 ˚C with con-
stant shaking at 150 rpm. Cell density was adjusted to 107 cells/mL and a 2 min sonication
treatment was performed using a 3 mm microtip probe with amplitude set to 20%, a 15 s pulse
and a 3 s interval between pulses (Vibra Cell VCX130, Sonics & Materials Inc., Newtown, CT,
USA). Cell viability of sonicated and non-sonicated cells, with and without ZnONPs exposure,
was measured by colony counts using drop-out assay analysis. Each experiment was performed
in triplicate.
2.8. Transcription rate analysis
The effect of AgNPs on transcription was examined according to Vidal-Aroca et al. [44].
Briefly, yeast cells (strain W303) were transformed with the expression vector p416, which
contains a galactose inducible β-galactosidase gene [45, 46]. Transformed cells were grown in
a synthetic medium lacking uracil (SC-URA) supplemented with 2% glucose. Cells were har-
vested (0.3–0.6 OD) and washed twice before adding SC-URA medium containing 2% galac-
tose. Cell density was adjusted to 107 cells/mL and cultures were aliquoted into 96-well
microtitre plates, where yeast cells were exposed to a range of sub-inhibitory concentrations of
AgNPs (0.9–9.0 μg/mL). The transcription inhibitor 6-azauracil (48 μg/mL) was used as a posi-
tive control. Plates were incubated at 30 ˚C for 6 and 10 h. A 20 μL aliquot from each well was
transferred into a 96-well microplate (black/clear Optilux flat bottom; BD Bioscience, San Jose,
CA, USA) containing 80 μL Z-buffer (in M: 0.06 Na2HPO4•7H2O, 0.04 NaH2PO4•H2O, 0.01
KCl, 0.001 MgSO4, 0.05 β-mercaptoethanol, pH 7) and the absorbance at 600 nm was mea-
sured with a Cytation 5 cell imaging multi-mode plate reader (BioTek, Winooski, VT, USA).
The reaction was initiated by adding 25 μL MUG (1 mg/mL in DMSO) to each well, followed
by a 15 min incubation at room temperature. The reaction was stopped by adding 30 μL 1 M
Na2CO3. β-Galactosidase activity was quantified by measuring fluorescence of the product
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MUB (390 nm ex./475 nm em.). MUB units for each replica (samples and controls) were calcu-
lated with the equation:
MUB ¼ F390=475  ðt  Abs595Þ ð3Þ
Where F390/475 is the sample fluorescence at the end of the reaction, t is the time of reaction in
minutes (min), and Abs595 is the absorbance of the cell suspension.
2.9. Cellular respiration analysis
The MTT assay was used to assess cellular respiration as described elsewhere [47]. Briefly,
yeast cells (S288C) were pelleted from overnight cell cultures, resuspended in distilled water,
and incubated overnight at 30 ˚C in order to starve the cells. Cells were pelleted and resus-
pended in distilled water at a 1:2 ratio. A 15 μL aliquot of the cell suspension was added to a
1.5 mL microcentrifuge tube containing 100 μL of each 100 mM MES, 1 M glucose, and 5 mg/
mL MTT. Sub-inhibitory concentrations of AgNPs (0.75–17.5 μg/mL) were added and vol-
umes were adjusted to 1 mL using distilled water. Sodium azide (2.5 mM) was used as an elec-
tron transport chain inhibitor (positive control) and glucose (100 mM) was used as a negative
control. Cells were incubated at 30 ˚C for 60 min, then placed on ice for 5 min and pelleted.
The cells were resuspended in DMSO to dissolve the formazan salt. Samples were centrifuged
and 100 μL of each supernatant was transferred to a microtitre plate. MTT reduction was
determined using a FLUOstar plate reader (BMG Labtech; Ortenberg, Hessen, Germany) at
595 nm. Each experiment was repeated five times.
2.10. Fluid-phase endocytosis analysis
The lucifer yellow (LY) uptake assay was performed as described previously [48, 49] to esti-
mate fluid-phase endocytosis of yeast cells. Briefly, yeast cells were grown to mid-log phase in
YPD supplemented with 30 mg/L each of uracil, adenine, and tryptophan (YPD-UAT). Cell
cultures were concentrated 10-fold by centrifugation. Aliquots (100 μL) of these concentrated
cell suspensions were mixed with 100 μL treatment solution containing sub-inhibitory concen-
trations of AgNPs (40 or 80 μg/mL). A buffer (pH 7) containing 12.5 mM sodium phosphate,
2.5 mM sodium fluoride and 2.5 mM of the endocytosis inhibitor sodium azide (ATPase
inhibitor), was used as a positive control. Samples were incubated at 30 ˚C for 15 min prior to
the addition of LY for a final concentration of 4 mg/mL. Samples were then incubated at 30 ˚C
for 1 h. Cells were pelleted and washed three times with 1 mL ice-cold succinate/azide buffer
(50 mM succinic acid, 20 mM NaN3, pH 5.0). Pellets were resuspended in 200 μL of the buffer
and observed by fluorescence microscopy (Axiophot, model, objective 40x and 100x, FITC
optics; Zeiss, Germany). The percentage of fluorescent cells was calculated by analyzing at least
six different fields of view, each with>20 cells.
2.11. Statistical analysis
The data are presented as mean ± standard error of the mean (SEM). Statistical analyses were
conducted using SigmaPlot (SPW 12; Systat Software, Inc., San Jose, CA). A one-way Analysis
of Variance (ANOVA) with a post-hoc Tukey method was used to assess significant differ-
ences in all assessed endpoints. A t-test was used to assess significant differences between
control and positive control groups when applicable. In all cases p 0.05 was considered
significant.
Nanoparticles toxicity
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Results and discussion
3.1. NPs characterization
The average size of ZnONPs was 278 nm according to DLS measurements (Fig 1A). Subse-
quent TEM analysis showed agglomerates/aggregates of ~200 nm in size composed of individ-
ual particles that are between 20 and 70 nm in diameter (Fig 1B). The size of the individual
ZnONPs is similar to the 50–70 nm size reported by the manufacturer. The average size of
AgNPs was 9 nm according to DLS measurements (Fig 1A), which was confirmed by TEM
analysis (Fig 1B). The measured size of AgNPs agrees with the 1–10 nm size range reported by
the manufacturer.
Fig 1. Size characterization of nanoparticles. (A) Dynamic light scattering (DLS) was used to assess the size of ZnONPs and AgNPs. Mean ± SEM are presented
(n 3). (B) Transmission electron microscopy images of ZnONPs and AgNPs (Note: the scale bars are 200 and 20 nm for ZnONPs and AgNPs, respectively).
https://doi.org/10.1371/journal.pone.0193111.g001
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It is noteworthy that the differences between ZnONPs and AgNPs potentially play a role in
their differential toxicity potential. Specifically, ZnONPs appear to be less stable in solution as
evidenced by the presence of agglomerates/aggregates. The aggregated ZnONPs may adhere to
cell surfaces while individual ZnONPs may penetrate cell membranes to act internally. In con-
trast, AgNPs appear to be more stable in solution and of a rather uniform size, such that indi-
vidual particles and/or Ag+ could potentially cross the cell membrane and affect internal
structures/molecules. As far as the release of Ag+ is concerned, the AgNPs used in the current
study were demonstrated previously to show minimal dissolution [50].
3.2. Minimum inhibitory concentrations and GDA analyses
The MIC100 values of ZnONPs and AgNPs using the yeast YPD-agar assay were
1.3<MIC1001.5 mg/mL and 0.10<MIC1000.12 mg/mL, respectively. On agar media, an
30% reduction in yeast colony size was observed at 1 mg/mL ZnONPs and 0.095 mg/mL
AgNPs (note: these are nominal concentrations); these concentrations were therefore chosen
for the high-throughput GDA phenotypic screenings. Out of the 4600 strains, 59 and 96
mutant strains were identified as highly sensitive to ZnONPs and AgNPs, respectively (S1 and
S2 Tables). Drug sensitivity drop-out assays were used to confirm the sensitivities of selected
mutant strains identified in the primary large scale screens. The results of these drop-out anal-
yses confirmed the sensitivity of the yjl095wΔ, ycl058cΔ, and yjl080cΔ strains to ZnONPs and
the sensitivity of the yjr104cΔ, yn1037cΔ and ybr085wΔ strains to AgNPs.
The highly sensitive mutants were clustered into functional categories (Fig 2). The highly
sensitive ZnONPs mutant strains formed 3 functional categories with significant enrichment
(Fig 2A). Transmembrane and membrane transport genes (p-value 1.3x10-3) formed the
most populated group (19%) of mutants highly sensitive to ZnONPs. Cellular ion homeostasis
genes formed the second most populated group (p-value 7.9x10-6), representing 17% of the
most sensitive. Genes involved in cell wall organization/biogenesis formed another major
group, representing 12% of the sensitive mutants (p-value 9.8x10-3). Similarly, mutants sen-
sitive to AgNPs could be categorized into several functional groups (Fig 2B). The largest
groups were transcription and RNA processing (16%, p-value 1.3x10-3), cellular respiration
(14%, p-value 5.7x10-4), and endocytosis and vesicular transport (12%, vesicle coat, p-value
 1.4x10-5). The above functional groups provide potential insights into the distinct modes of
action of ZnONPs and AgNPs in yeast that were tested by secondary assays (see below).
3.3. Cell membrane disruption analyses in ZnONPs-treated yeast
GDA analysis identified a significant enrichment (19%, p-value 1.3x10-3) of ZnONPs-sensi-
tive strains with deletions of genes involved in transmembrane and membrane transport/orga-
nization. These genes include PKR1, which codes for a V-type proton-translocating ATPase
assembly factor involved in transport of protons across intracellular membranes of organelles,
and ERG2 and ERG28, which code for proteins involved in biosynthesis of ergosterol, a sterol
that has similar functions to cholesterol in animal cell membranes (e.g. membrane fluidity).
Furthermore, there was an enrichment of mutants with deletions in genes involved in ion
homeostasis (17%, p-value 7.9x10-6), such as FTR1 (codes for an ion transporter), GEF1
(involved in cation homeostasis), and SPF1 (mediates Ca2+ homeostasis). These results suggest
that ZnONPs could disrupt intracellular processes, but most importantly impair the proper
function of the cell membrane. Indeed, the ability of ZnONPs to disrupt the cell membrane in
E. coli has been demonstrated previously and proposed as one of the antimicrobial mecha-
nisms [51, 2].
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Fig 2. Functional distribution of deletion mutants that are highly sensitive to ZnONPs and AgNPs. (A) Clustering
of the 59 most sensitive deletion mutant strains to 1 mg/mL ZnONPs reveal that mutants lacking genes involved in
membrane and transmembrane transport, ion homeostasis and transport, and cell organization of biogenesis
encompass the significantly enriched groups. (B) Clustering of the 96 most sensitive deletion mutant strains to 0.095
mg/mL AgNPs indicate that mutants lacking genes involved in transcription, cellular respiration, and endocytosis and
vesicular transport represent the significantly enriched groups.
https://doi.org/10.1371/journal.pone.0193111.g002
Nanoparticles toxicity
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The effects of ZnONPs on the cell membrane were investigated using several approaches.
There was a dose-dependent increase in fluorescence signal after treatment of carboxyfluores-
cein-containing liposomes with ZnONPs (0.03–0.2 mg/mL), such that treatment with the
highest concentration resulted in 24% leakage (Fig 3A). The influence of ZnONPs on lipo-
somes may be attributed to the release of Zn2+ ions that alter liposome conformation by an
electrostatic interaction and modify permeability [52]. There was also a dose-dependent
increase in the percentage of trypan blue stained cells observed upon treatment with ZnONPs
(Fig 3B), which provides further evidence that ZnONPs disrupt the cell membrane resulting in
either increased uptake or decreased efflux of trypan blue.
Moreover, treatment with 1.0 mg/mL ZnONPs affected cell membrane depolarization (Fig
3C). The assay relies on an electrical potential-sensitive fluorescent dye [DiSBAC2(3)] that
only penetrates into cells with depolarized cell membranes and provides a characteristic fluo-
rescent signal when it binds to intracellular proteins. The increase in fluorescent signal due to
ZnONPs exposure was comparable to that of the proton ionophore CCCP (a depolarizing
agent) used as a positive control. Both treatments showed a second peak in the fluorescent
region (104−105) on the FL2-H axis, indicating that the dye was able to enter cells and bind to
intracellular proteins.
Fig 3. Cell membrane disruption by ZnONPs. (A) Carboxyfluorescein leakage from liposomes that were exposed to
various concentrations of ZnONPs for 30 min. (B) Trypan blue exclusion assay in yeast cells following a 2 h exposure to
various concentrations of ZnONPs. Mean ± SEM are presented (n 3). Significant differences are indicated with letters.
(C) Membrane depolarization analysis in yeast cells that were subjected to: 0.01 mM citric acid (negative control), 20 μM
CCCP (carbonyl cyanide 3-chlorophenylhydrazone; positive control), and 1 mg/mL ZnONPs. The histograms show the
number (Count, Y-axis) of yeast cells in a sample with depolarized membranes (FL2-H interval = 104–105) and cells at
resting potential (FL2-H = 102–104).
https://doi.org/10.1371/journal.pone.0193111.g003
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The results of the three methods that assessed cell membrane integrity were consistent in
indicating that ZnONPs disrupt the cell membrane of yeast. Altogether our observations vali-
date the inference from the chemical-genetic profile analysis that yeast cell membrane and
membrane transport are altered by ZnONPs, similar to observations with bacterial cells (e.g.
E. coli [53]). By extension, ZnONPs could alter ion homeostasis, an effect that was previously
reported in human cells [54].
3.4. Cell wall disruption analysis in ZnONPs-treated yeast
Another major group of mutants that was highly sensitive to ZnONPs had deletions in cell
wall organization and biogenesis genes (p-value 9.8x10-3), and represented 12% of the most
sensitive mutant strains (Fig 2A). Included in this group were gene deletions such as KRE6,
HOC1 and BCK1, involved in glucan biosynthesis, cell wall mannan biosynthesis and control
of cell integrity, respectively. Any alteration in cell wall composition caused by gene deletions
may modify cell wall rigidity and lead to a higher sensitivity to chemicals that target cell wall
integrity. To test the effect of ZnONPs on cell wall functions, a cell wall integrity assay was car-
ried out by exposing ZnONPs-treated cells to mild sonication. The perturbation of the cell wall
architecture resulting from a physical agent such as mild sonication can be enhanced by expos-
ing cells to chemicals that interfere with cell wall integrity [55]. Indeed, exposure to ZnONPs
enhanced the sonication-induced disruption of yeast cell wall functions in a dose-dependent
manner. For example, cells exposed to 0.5 mg/mL ZnONPs displayed a 50% mortality com-
pared to control (non-ZnONPs-treated sonicated cells), whereas a dose of 1.5 mg/mL ZnONPs
had no surviving cells (Fig 4). These results provide evidence of an effect of ZnONPs on cell
wall sensitivity to sonication.
This experiment supported our inference from the GDA analysis that ZnONPs interfere
with cell wall functions in yeast. This effect of ZnONPs on the yeast cell wall resemble the find-
ings by Hassan et al. [56], based on scanning electron microscopy with Aspergillus spp., dem-
onstrating that ZnONPs electrostatically interact with cell wall biomolecules to alter the spatial
configuration of the cell wall.
3.6. Transcription rate analysis in AgNPs-treated yeast
Based on GDA analyses, 16% of the most sensitive deletion mutants to AgNPs were in the
transcription and RNA processing category (p-value 1.3x10-3). Deleted genes included in
this group are THP2 and THO2 that code for transcription elongation factors, and CTK1 that
codes for a RNA processing protein (S2 Table). To test the effect of AgNPs on transcription, a
reporter β-galactosidase expression-based assay was carried out. This assay has been used pre-
viously to investigate transcription rates in Salmonella [57] and in yeast [58, 59]. The effect of
AgNPs on the β-galactosidase enzymatic activity was evaluated as an indirect measure of tran-
scription [46]. Enzymatic activity was estimated in terms of the MUB (4-methylumbelliferon
fluorescent product) released after MUG was hydrolyzed by expressed β-galactosidase. The
assay showed that AgNPs reduced gene expression in a dose-dependent manner (Fig 5A). For
example, exposure of 2.14 μg/mL AgNPs resulted in a 36% decrease in β-galactosidase activity
compared to the negative control (no-AgNPs), and a concentration of 9 μg/mL caused a 64%
decrease in activity, which is comparable to the effect of 48 μg/mL 6-azauracil, a known inhibi-
tor of transcription.
The effect of AgNPs on transcription may be explained by the ‘hard-soft acid base theory
(HSAB)’, which states that ‘soft’ acids such as Ag+, among other metals, can bind sulfur or
phosphorous in ‘soft’ bases, altering protein structure or function [59–61]. Another potential
explanation is that silver ions could be indiscriminately incorporated as metal cofactors into
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Fig 4. ZnONPs compromise cell wall integrity. (A) Cells were exposed to various concentrations of ZnONPs,
subjected to mild sonication, diluted and then spotted onto YPD and compared to non-sonicated counterparts. (B)
Cell survival rate (% survival sonicated/non-sonicated cells) was then quantified. Mean ± SEM are presented (n 3).
Significant differences are indicated with letters.
https://doi.org/10.1371/journal.pone.0193111.g004
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enzymes (ion mimicry), interfering with regular metabolic functions [62, 60]. It is our under-
standing that the effect of AgNPs on transcription has not been previously reported. More
studies are required to determine the specific target of AgNPs in the transcription process.
3.7. Cellular respiration analysis in AgNPs-treated yeast
The second largest functional group that resulted in high sensitivity to AgNPs in the GDA
analysis comprised mutants lacking genes that code for proteins involved in cellular respira-
tion (14%, p-value 5.7x10-4). Deleted genes included in this group are IDH1 (encodes the
enzyme for the oxidation of isocitrate to alpha-ketoglutarate), SOD1 (codes for cytosolic cop-
per-zinc superoxide dismutase that detoxifies superoxide), and ETR1 (codes for a 2-enoyl
thioester reductase that is involved in aerobic respiration). We tested the effect of AgNPs on
cellular respiration with the MTT assay. MTT monitors electron transport chain performance,
Fig 5. Transcription rate, cellular respiration, and endocytosis in yeast cells exposed to AgNPs. (A) β-galactosidase reporter gene expression assay was used to
estimate transcription rate in response to AgNPs or 6-azauracil (positive control). β-galactosidase activity in treatments is expressed relative to no-AgNPs control
(negative control). (B) MTT reduction assay was used to estimate cellular respiration in response to AgNPs or sodium azide (positive control). (C) Brightfield,
fluorescence, and merged images of negative control, AgNPs (80 μg/mL), and positive control (NaN3) groups. The cells that internalized Lucifer Yellow (LY) are
fluorescent. (D) The uptake of LY was used to estimate endocytosis in response to AgNPs. Percentage of fluorescent cells relative to control was determined by
examining at least 6 different fields, each with>20 cells. Mean ± SEM are presented (n 3). Significant differences are indicated with letters.
https://doi.org/10.1371/journal.pone.0193111.g005
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since it is reduced by mitochondrial succinate dehydrogenase to the formazan salt that can be
measured spectrophotometrically [63, 47]. Sodium azide is an ETC inhibitor that blocks com-
plex IV in the ETC and was used as a positive control. We observed a 42% reduction in forma-
zan formation when the yeast cells were exposed to 5 μg/mL AgNPs, and a 64% reduction
when exposed to 10 μg/mL AgNPs (Fig 5B). The results indicate that the MTT reduction by
ETC is inhibited by AgNPs.
Of interest, the level of ETC inhibition by AgNPs at concentration of 10 μg/mL is greater
than that of our positive control, 2.5 mM sodium azide (Fig 5B). This might be due to the fact
that sodium azide inhibits the heme groups of oxidases, including the cytochrome oxidases
(complex IV), but it does not affect the reducing potential from other sources, such as oxido-
reductases anchored in non-mitochondrial membranes [64, 65]. It was previously speculated
that AgNPs inhibition of E. coli growth is due to the interaction of silver ions with the thiol
groups frequently encountered in membrane and antioxidant proteins, including thioredoxin
reductase and superoxide dismutase [66]. Alteration of mitochondrial membrane proteins can
trigger permeabilization of membranes and depolarization in mitochondria, provoking an
impaired electron transfer that results in oxidative stress [60, 67–68].
3.8. Fluid-phase endocytosis analysis in AgNPs-treated yeast
In our high-throughput GDA study, the group representing endocytosis and vesicular transport
was also highly enriched among AgNPs-sensitive mutants (Fig 2B). This category represented
12% (p-value 1.4x10-5) of highly sensitive mutant strains comprising deletions of genes
involved in clathrin-mediated endocytosis and vesicular transport, such as ENT3,APM4, APL1,
APL2 and AAC1. To further study the effect of AgNPs on endocytosis, a fluid-phase endocytosis
assay was performed based on Lucifer Yellow (LY) uptake. LY is a highly hydrophilic dye, whose
internalization is mediated by endocytosis rather than passive diffusion [49]. The accumulation
of LY can be investigated by fluorescence microscopy and it has been used to assess endocytosis
performance [69], where defects in endocytosis can be observed as differences in fluorescence
localization and intensity [48, 70]. The fluorescence microscopy assay showed a marked differ-
ence in the number of cells internalizing the LY between control and AgNPs-exposed cells (Fig
5C). The percentages of LY-stained yeast cells exposed to 40 and 80 μg/mL AgNPs were 37.1%
and 22.6%, respectively, comparable to the positive control (2.5 mM NaN3), where only 13.1% of
yeast cells were LY-stained (Fig 5D). NaN3 inhibits ATP hydrolysis which may interfere with the
vacuolar pH balance and thus perturb endocytosis [71, 72]. These observations further validate
the results of the GDA screening that suggested AgNPs affect endocytosis.
The effect of AgNPs on endocytosis may be explained by the capability of metal ions to gen-
erally impair membrane function [73, 74]. Previous studies demonstrated that AgNPs affected
cell membrane morphology in E. coli and V. cholera, leading to defective transmembrane
transport and increased permeability [75]. Similarly, Kim et al. [76] reported that AgNPs
altered the membrane dynamics of Candida albicans, changing the chemi-osmotic potential
and altering lipid peroxidation. It is well established that modification of membrane dynamics
can affect vesicular membrane trafficking [77]. These perturbations can be attributed to the
capability of metal-nanomaterials like AgNPs to electrostatically interact with negatively
charged functional groups such as COO-, SH- or phosphorous. These functional groups are
found in proteins and phospholipids, including those in cellular membranes.
Conclusions
ZnONPs and AgNPs are commonly used ENMs that have been reported to have a broad spec-
trum of toxic effects against bacteria, fungi, viruses and algae [9, 10, 65]. The present study
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extends our understanding of antimicrobial activity using yeast as a model organism, and
uncovers complex and distinct modes of action of ZnONPs and AgNPs. Our results support
the idea that antifungal activity of ZnONPs is primarily driven by disruption of cell mem-
brane-cell wall complex, and associated processes, such as ion homeostasis. On the other
hand, AgNPs inhibit yeast growth by reducing rates of transcription, cellular respiration, and
endocytosis. This study is among the first to demonstrate the usefulness of large-scale high-
throughput genomics screening approach to study the toxicity of ENMs. The speed and ease of
use, coupled with relatively simple data analysis makes chemical-genetic analysis using GDA
an ideal tool for the identification of cellular targets that are affected by ENMs.
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